Cell Based Assays and FDA Approval - Drug Discovery Digest

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Cell Based Assays

FDA Approval

ChEMBL 34 is out!

The ChEMBL-og

APRIL 16, 2024

University of Dundee: T. 1813 bioactivities in total have been added.

Clinical Trials

Clinical Trials FDA Cell Based Assays Compound Screening

Use of Ultra-High-Throughput Screening in Discovery of COVID-19 Virus Structure

PerkinElmer

AUGUST 13, 2020

The virus, which can cause a severe form of pneumonia and lead to acute respiratory distress, currently has no FDA-approved targeted therapeutic or vaccine. Of these 10,000 compounds, some were drugs already approved for other uses; others were drug candidates being used in clinical trials.

Virus

Virus Cell Based Assays FDA Approval Clinical Trials

Accelerating Drug Discovery Through Repurposing

DrugBank

FEBRUARY 12, 2025

Key techniques include high-throughput screening (HTS), cell-based assays, and animal models. The National Institutes of Health (NIH) Clinical Collection , a library of FDA-approved drugs, is widely used for HTS in drug repurposing initiatives.

Cell Based Assays

Cell Based Assays Drugs Pharmacokinetics Disease

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

ChEMBL 34 is out!

Use of Ultra-High-Throughput Screening in Discovery of COVID-19 Virus Structure

Accelerating Drug Discovery Through Repurposing

Webinars

Stay Connected